Spatial genomics has existed for many years, but it has often been limited by complex imaging systems, specialized equipment, and $$$.
With IRISeq, we wanted to simplify this to a simple PCR rxn. https://t.co/jmS3N6PRu2
We are heartbroken to have lost our founder, who provided so much inspiration, but we are all honored to carry on the science he loved so much. https://t.co/IR7QX8g0Q0 #neuroscience#biology
I couldn’t be prouder to announce that @tanmana_mitra’s thesis work identifying how metabolic demand drives terminal T cell exhaustion is out today in @ImmunityCP : https://t.co/KyE1YTarXp
Wow such cool work: A human developmental and adult brain atlas benchmarks dopaminergic stem cell models and cell therapy candidates
https://t.co/vutPOijWKW
We’re happy to announce 2 releases today:
- 🧠Brain2qwerty v1 is published at @NatureNeuro
- 🚀 Brain2Qwerty v2 is now publicly released
Explore how we decode sentences from non-invasive brain recordings: https://t.co/IdR6gK2hcd
Links:
📄v1 Nature Neuro: https://t.co/wnRjc9W9gI
📑v2 Meta preprint: https://t.co/oSfLOQFcvg
💻Code: https://t.co/Xbe0XWfWQL
📊Data: https://t.co/SCBbs4AhTg
📝Blog: https://t.co/15RvsAaXlH
🧵Thread: https://t.co/d8FJrVyDut
Our CytoSignal paper is now published in @NatureGenet! During revision, we generated a one-of-a-kind dataset with direct measurements of ligand-receptor protein interactions in situ in the mouse embryo, along with Visium HD spatial transcriptomics. https://t.co/UmzcIdZwfp
I’m delighted to finally share work from my PhD with @dalygene and @s_mccarroll.
We show how human genetics and AlphaFold3-predicted protein structure can be combined to discover new mechanisms underlying missense risk in brain disorders.
1/n
https://t.co/slc7xgCMHV
Delighted to share our new preprint on xVDM (cross-linked volumetric DNA microscopy), turning the protein scaffolds inside intact tissue into dense, DNA-encoded proximity networks for transcriptome and protein mapping.
https://t.co/ke51NqDmwe
Exciting breakthrough technology from the lab, now live in @CellCellPress ! Instead of cutting the genome where proteins bind (e.g., Cut&Tag), D&D-seq scars the DNA with a deaminase, allowing single cell genome mapping of TFs and chromatin remodellers!
Thank you so much Jun! This was a great team effort with the brilliant but Twitterless Aileen, an MD-PhD student in the @junyue_cao Lab. It has been such a privilege to work with everyone in the lab and to call @RockefellerUniv my PhD home.
New preprint alert! 🚀 Across 60 human cancer cell lines spanning 20 cancer types, single-cell RNA+ATAC reveals pan-cancer cell-state heterogeneity, core gene-regulatory networks, and an EMT axis conserved across tissue origins.
Huge congrats to first author @xu_zxu, who recently defended his PhD, and Aileen Ugurbil from our lab @RockefellerUniv! https://t.co/4fNQJlJY3m
New preprint alert🚀 Using TrackerSci, we quantified the birth rate of each cell type across the whole organism, and how these rates are rewired with age.
Huge congrats to the incredible Dr. Lu @ziyu__lu from @RockefellerUniv, who just defended today!
https://t.co/h50Swm03Lh
Today at #ASCO26, more results about the newest clinical trial of daraxonrasib: In the Phase III RASolute-302 trial, a once-daily RAS(ON) inhibitor nearly doubled median overall survival (13.2 vs 6.7 months) and reduced the risk of death by ~60% versus chemotherapy in previously treated metastatic pancreatic cancer.
KRAS was once considered “undruggable.” This is what persistence in science looks like.
A landmark moment for targeted therapy and for patients who desperately need better options. #CancerResearch #PancreaticCancer
There hasn't previously been a treatment vs pancreatic cancer this successful. Striking improved (a > doubling) survival results @NEJM and @ASCO today with daraxonrasib, which also became available via an FDA approved early access program and began shipping to physicians this week @RevMedicines
https://t.co/e04jqJMPw0
Cardiac "remuscularization" for treating severe heart failure with patched heart muscle derived from stem cells (a biological ventricular assist device) successful in 12 of 20 patients @NEJM
https://t.co/mAwgj2rAwE https://t.co/3ogxaJFDE0
Long-term editing of brain circuits with engineered electrical synapses! I still remember years ago when @KafuiDzirasa from @DukeU@hhmi_science called me beaming with excitement about this new technology. Here it is today @Nature.
https://t.co/5fnW6zW0z6